Stephen Mullennix, Chief Operating Officer at UroGen Pharma Ltd. (URGN), sold 145 shares at $24.35 ($4K) on 2020-04-27, disclosed to the SEC on 2020-04-28.
Open-market sale of $4k URGN by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| URGN | SELL | 2019-11-18 | $16K | — | Filing → |
| URGN | SELL | 2019-08-16 | $19K | — | Filing → |
| URGN | SELL | 2019-05-16 | $23K | — | Filing → |